First-Ever Clinical Trial Exclusively in Black and Hispanic / Latinx People Living With Multiple Sclerosis Shows Genentech's Ocrevus Effectively Manages Disease Activity | Region

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct 11, 2023--

Related Keywords

South San Francisco ,California ,United States ,Puerto Rico ,Milan ,Lombardia ,Italy ,Spain ,Kenya ,Spanish ,Mitzi Joi Williams ,Bruno Eschli ,Loren Kalm ,Michelle Mccourt ,Jo Dulay ,Quita Highsmith ,Roche Group ,Research In Multiple Sclerosis ,Joi Life Wellness Ms Center ,Genentech ,Americas Committees ,Multiple Sclerosis ,Joi Life Wellness ,Important Safety ,Multifocal Leukoencephalopathy ,Ocrevus Pregnancy ,Important Safety Information ,Prescribing Information ,Based Estimates ,Media Contact ,Business Wire ,Region ,